Therapeutic RNA Nanotechnology: Immunomodulation and Dynamicity

1229 Pages·2021·94.283 MB·English

by  Kirill A. Afonin, Morgan Chandler

Therapeutic

RNA Nanotechnology

Therapeutic

RNA Nanotechnology

Immunomodulation and Dynamicity
edited by

Kirill A. Afonin | Morgan Chandler
Published by
Jenny Stanford Publishing Pte. Ltd.
Level 34, Centennial Tower
3 Temasek Avenue
Singapore 039190
Email: [email protected]
Web: www.jennystanford.com
British Library Cataloguing-in-Publication Data
A catalogue record for this book is available from the British Library.
Therapeutic RNA Nanotechnology: Immunomodulation
and Dynamicity
All rights reserved. This book, or parts thereof, may not be reproduced in any form
Copyright © 2021 by Jenny Stanford Publishing Pte. Ltd.
or by any means, electronic or mechanical, including photocopying, recording
or any information storage and retrieval system now known or to be invented,
without written permission from the publisher.
For photocopying of material in this volume, please pay a copying fee through
the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923,
USA. In this case permission to photocopy is not required from the publisher.
ISBN 978-981-4877-18-3 (Hardcover)
ISBN 978-1-003-12200-5 (eBook)
Dedication
Kirill Afonin dedicates this book to the memory of his mentor
and teacher, Prof. Neocles Leontis, who left us too early.
Without him, this work would have never been possible.

Contents

Preface
Part I Nano design xlvii
1. Generating New Specific RNA Interaction Interfaces

Using C-Loops 3

Kirill A. Afonin and Neocles B. Leontis

1.1 Introduction 4

1.2 Materials and Methods 5

1.2.1 Design of the C-Loop-Containing

Tectonics 5

1.2.2 RNA Preparation 6

1.2.3 pCp Labeling of RNA Molecules 7
K

1.2.4 Assembly Experiments 7

1.2.5 Dissociation Constants ( d)

Determination 8
2+

1.2.6 Lead (Pb )-Induced Cleavage 8

1.3 Results 8

1.3.1 Design and Nomenclature of C-Loop-

Containing Tecto-RNA Molecules 8
K

1.3.2 Assembly Experiments and

Dissociation Constants ( d’s) 9

1.3.3 Competition Experiments 13

1.3.4 Monitoring C-Loop Formation by

Pb(II)-Induced Cleavage 14

1.4 Discussion 16
2. 1Sp.5e cific CRoNnAc lSueslifo-Ans sembly with Minimal Paranemic
19
Motifs 21

Kirill A. Afonin, Dennis J. Cieply, and Neocles B. Leontis

2.1 Introduction 22
2.2 Materials and Methods 26
viii Contents

2.2.1 Sequence Design 26

2.2.2 RNA Preparation 27

2.2.3 Radio-Labeling of RNA Molecules 27

2.2.4 Assembly Experiments 27
K

2.2.5 Determination of Dissociation

Constants ( d) 28
2+

2.2.6 Lead (Pb )-Induced Cleavage 29

2.3 Results 29

2.3.1 Designs of RNA Molecules for

Paranemic Assembly 29

2.3.2 Paranemic RNA Self-Assembly 30

2.3.3 Using Pb(II) to Probe the Formation

of Paranemic Complexes 31

2.3.4 Kinetic Exchange 33

2.3.5 Sequence Specificity 35

2.3.6 Determination of Dissociation

Constant for 3HT Complexes 39

2.4 Discussion 40
3. 2In.5 v itro CAossnecmlubsliyo no f Cubic RNA-Based Scaffolds
42
designed in silico 45

Kirill A. Afonin, Eckart Bindewald, Alan J. Yaghoubian,

Neil Voss, Erica Jacovetty, Bruce A. Shapiro, and

Luc Jaeger

3.1 Introduction 46

3.2 Rational Design of a Nanocube 47

3.3 Nanocube Self-Assembly 49

3.4 Comparison of RNA, DNA and RNA/DNA

Nanocubes 51

3.5 Structural Characterization by DLS and

Cryo-EM 53

3.6 RNA Nanocube Functionalization 55

3.7 Conclusion 58

3.8 Methods 58

3.8.1 RNA Preparation 58

3.8.2 pCp Labelling of RNA Molecules 59
3.8.3 ATP Labelling of DNA 59
Contents ix

3.8.4 Self-Assembly of RNA and DNA Cubes 59
K

3.8.5 Non-denaturing PAGE, TGGE

Experiments and d Measurements 59

3.8.6 Assembly of RNA Cubes during

Transcription 60

3.8.7 Dynamic Light Scattering 60

3.8.8 Cryo-EM Imaging 61
4. Self-Asse3m.8b.9li ng RFNluAo Nreasncoernincges E Bxapseerdim oenn
ts 61
RNAI/II Inverse Kissing Complexes 67

Wade W. Grabow, Paul Zakrevsky, Kirill A. Afonin,

Arkadiusz Chworos, Bruce A. Shapiro, and Luc Jaeger

4.1 Introduction 68

4.2 Results and Discussion 71

4.2.1 Nanoring Design and Self-Assembly 71

4.2.2 Structural Characterization of

Nanoring Assembly 72

4.2.3 Exploring Structural Flexibility versus

Structural Rigidity on Nanoring

Assembly 73

4.2.4 Design and Characterization of

Programmable Nanorings 77

4.2.5 Nanorings with Increased Resistance

toward Ribonuclease Degradation in

Blood Serum 81

4.2.6 Nanoring Functionalization with

siRNAs 83

4.3 Conclusion 84

4.4 Materials and Methods 85

4.4.1 RNA Structural and Sequence Design 85

4.4.2 RNA Synthesis 86

4.4.3 RNA Assembly, Native PAGE, and

TGGE Experiments 86

4.4.4 AFM Characterization 86

4.4.5 Specificity Study and Determination
K

of Equilibrium Constant of
Dissociation ( d) 87